Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2019 Dec;8(Suppl 6):S589-S591.
doi: 10.21037/tcr.2019.06.43.

Lomustine and temozolomide for newly diagnosed glioblastoma with methylated MGMT promoter: Lessons from the CeTeG/NOA-09 trial

Ivo W Tremont-Lukats  1 , Bin S Teh  2
Affiliations
Editorial

Lomustine and temozolomide for newly diagnosed glioblastoma with methylated MGMT promoter: Lessons from the CeTeG/NOA-09 trial

Ivo W Tremont-Lukats et al. Transl Cancer Res. 2019 Dec.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/tcr.2019.06.43). The authors have no conflicts of interest to declare.

Comment on

References

    1. Herrlinger U, Tzaridis T, Mack F, et al. Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial. Lancet 2019;393:678-88. 10.1016/S0140-6736(18)31791-4 - DOI - PubMed
    1. Herrlinger U, Rieger J, Koch D, et al. Phase II trial of lomustine plus temozolomide chemotherapy in addition to radiotherapy in newly diagnosed glioblastoma: UKT-03. J Clin Oncol 2006;24:4412-7. 10.1200/JCO.2006.06.9104 - DOI - PubMed
    1. Lea MA. Effects of carbamoylating agents on tumor metabolism. Crit Rev Oncol Hematol 1987;7:329-71. 10.1016/S1040-8428(87)80004-5 - DOI - PubMed
    1. Van den Bent MJ. Adult glioma: Updates on clinic. EANO 2018 Educational Syllabus. Stockholm: European Association of Neuro-Oncology; 2018:16-23.
    1. Stupp R. Drug development for glioma: are we repeating the same mistakes? Lancet Oncol 2019;20:10-2. 10.1016/S1470-2045(18)30827-1 - DOI - PubMed